tradingkey.logo
tradingkey.logo
검색

Integra Lifesciences Holdings Corp

IART
관심 목록에 추가
18.050USD
+0.160+0.89%
종가 07/02, 13:00ET시세는 15분 지연됩니다
1.41B시가총액
손실P/E TTM

Integra Lifesciences Holdings Corp

18.050
+0.160+0.89%

자세한 내용은 Integra Lifesciences Holdings Corp 회사

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Integra Lifesciences Holdings Corp 정보

종목 코드 IART
회사 이름Integra Lifesciences Holdings Corp
상장일Aug 16, 1995
CEOPoul (Mojdeh)
직원 수4396
유형Ordinary Share
회계 연도 종료Aug 16
주소1100 Campus Road
도시PRINCETON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호08540
전화16092750500
웹사이트https://www.integralife.com/
종목 코드 IART
상장일Aug 16, 1995
CEOPoul (Mojdeh)

Integra Lifesciences Holdings Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%

자주 묻는 질문

Integra Lifesciences Holdings Corp의 상위 5대 주주는 누구인가요?

Integra Lifesciences Holdings Corp의 상위 5대 주주는 다음과 같습니다: Ms. Mojdeh Poul

Integra Lifesciences Holdings Corp(IART)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Integra Lifesciences Holdings Corp의 주식을 보유한 기관은 총 574곳이며, 이들이 보유한 주식의 총 가치는 약 82.80M로 전체 발행 주식의 106.43%를 차지합니다. 이는 2025Q4 대비 -14508057.00 증가한 수치입니다.

Integra Lifesciences Holdings Corp의 최대 수익원은 무엇인가요?

2026Q1 기준, Integra Lifesciences Holdings Corp의 Neurosurgery 부문이 가장 높은 매출을 기록했으며, 금액은 827.67M로 전체 매출의 50.61%를 차지했습니다.